Cutaneous Drug Reactions in Human Immunodeficiency Virus Infection

Authors:
  • SCSerge A. Coopman
    Serge A. Coopman
  • RSRobert S. Stern
    Robert S. Stern

Abstract
In this issue of theArchives, Porteous and Berger1describe eight individuals with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) who experienced severe cutaneous adverse reactions to drugs, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Also in this issue, Garty2reports such a case. These adverse events, which were seen in individuals who received multiple medications, occurred from 1 to 21 days (median, 8 days) after therapy with the suspect drug was initiated. Five patients had had a history of prior maculopapular drug eruptions, and two of them had had a previously documented reaction to the suspect drug. In three of these eight cases sulfonamides were suspected. As suggested in this report, other drugs appear to be causes of these reactions as well, but the magnitude of this risk with other drugs is far less clear. The authors note that patients with AIDS and toxoplasmosis